Jahir Rodríguez - Rivera (@j_rdzrivera) 's Twitter Profile
Jahir Rodríguez - Rivera

@j_rdzrivera

MD @TecDeMty | EMIS 41 |🫀| 🇲🇽

ID: 1575876005402595328

calendar_today30-09-2022 15:51:41

63 Tweet

41 Followers

164 Following

Dr Shariq Shamim (@shariqshamimmd) 's Twitter Profile Photo

We are told “In era of high sensitivity troponin, unstable angina doesn’t exist and its safe to discharge from ER if HS troponin negative.”Here is an anatomy in patient with “atypical CP with negative HS troponin X3”.

We are told “In era of high sensitivity troponin, unstable angina doesn’t exist and its safe to discharge from ER if HS troponin negative.”Here is an anatomy in patient with “atypical CP with negative HS troponin X3”.
Alfonso Valle (@vallealfonso) 's Twitter Profile Photo

🔴Asundexian versus Apixaban in Patients with Atrial Fibrillation #OCEANIC-AF 👥14810 with atrial fibrillation at risk for stroke ⏰over 11 months 🌏. 👉Asundexian 50 mg once daily was inferior for prevention of stroke and systemic embolism 🆚 Apixaban 📍The majority of

🔴Asundexian versus Apixaban in Patients with Atrial Fibrillation #OCEANIC-AF

👥14810 with atrial fibrillation at risk for stroke
⏰over 11 months 🌏.

👉Asundexian 50 mg once daily was inferior for prevention of stroke and systemic embolism 🆚 Apixaban

📍The majority of
Almudena Castro Conde (@almucastro01) 's Twitter Profile Photo

3er pilar del tto de ICFEp: FINERENONA El FINEARTS-HF muestra: - ⬇️ 16% ☠️CV + 🏥IC - ⬇️. 18% 🏥IC En 3 años hemos encontrado 3 grupos farmacológicos para una enfermedad q hasta entonces era huérfana. Buenas noticias sobre todo para los pacientes

3er pilar del tto de ICFEp:
    FINERENONA
El FINEARTS-HF muestra:
- ⬇️ 16% ☠️CV + 🏥IC
- ⬇️. 18% 🏥IC
En 3 años hemos encontrado 3 grupos farmacológicos  para una enfermedad q hasta entonces era huérfana.
Buenas noticias sobre todo para los pacientes
TecCardiology (@teccardiology) 's Twitter Profile Photo

Remarkable presentations about state-of-the-art techniques for AFib management with Dr. Valderrabano 🇺🇸 and Dr. Essebag 🇨🇦 @MiguelVldrbno Mauricio Cortes

Remarkable presentations about state-of-the-art techniques for AFib management with Dr. Valderrabano 🇺🇸 and Dr. Essebag 🇨🇦

@MiguelVldrbno <a href="/mauricioca4321/">Mauricio Cortes</a>
Jahir Rodríguez - Rivera (@j_rdzrivera) 's Twitter Profile Photo

Great first speaker at Cardiogenic Shock LATAM! Sandeep Nathan, MD, MSc on Current Management of CS-AMI 🫀 👉 Rapid reperfusion & early recognition matter 👉 Vasopressors + pMCS tailored to patient 👉 Avoid bleeding/vascular complications 👉 Shock teams & system-based care

Great first speaker at Cardiogenic Shock LATAM! 

 <a href="/SandeepNathanMD/">Sandeep Nathan, MD, MSc</a> on Current Management of CS-AMI 🫀

👉 Rapid reperfusion &amp; early recognition matter
👉 Vasopressors + pMCS tailored to patient
👉 Avoid bleeding/vascular complications
👉 Shock teams &amp; system-based care
Jahir Rodríguez - Rivera (@j_rdzrivera) 's Twitter Profile Photo

Second Panel on #CShockLATAM25: HF CS! 🫀 👉🏻 Great clinical case of AHF by Jorge A Ortega Hdz, FACC & FESC 👉🏻 Key clues for identifying Bi-V CS by Dr. Guilherme Olveira 👉🏻 CS in women: sex-specific differences in CS by Dr Manreet Kanwar Keeping it up with amazing lectures! #CShockLATAM2025

Second Panel on #CShockLATAM25: HF CS! 🫀

👉🏻 Great clinical case of AHF by <a href="/Jorgeheartshock/">Jorge A Ortega Hdz, FACC & FESC</a> 
👉🏻 Key clues for identifying Bi-V CS by Dr. Guilherme Olveira
👉🏻 CS in women: sex-specific differences in CS by Dr Manreet Kanwar

Keeping it up with amazing lectures!
#CShockLATAM2025
Jahir Rodríguez - Rivera (@j_rdzrivera) 's Twitter Profile Photo

🚨 #CShockLATAM25 Module 3: Pulmonary Embolism + CS 🫀 “PE may be acute, but the clot rarely is” – Sripal Bangalore ⚡ Takeaways: Multidisciplinary care, PERT Teams & early recognition saves lives! 🔑 Novel modalities on PE therapy 💎 Normotensive PE!

🚨 #CShockLATAM25 Module 3: Pulmonary Embolism + CS 🫀

“PE may be acute, but the clot rarely is” – <a href="/SripalBangalore/">Sripal Bangalore</a>

⚡ Takeaways: Multidisciplinary care, PERT Teams &amp; early recognition saves lives!

🔑 Novel modalities on PE therapy

💎 Normotensive PE!
Marwan Jumean, MD (@jumeanmarwan) 's Twitter Profile Photo

A perfect mix of science and insightful knowledge. Great people, an inspiring location, and top-notch organization. #CShockLATAM25 Excited to be part of 2026!

A perfect mix of science and insightful knowledge. Great people, an inspiring location, and top-notch organization. #CShockLATAM25  Excited to be part of 2026!
Jahir Rodríguez - Rivera (@j_rdzrivera) 's Twitter Profile Photo

Kicking off Day 2 at #CShockLATAM2025 with impactful clinical cases! 🚨 Key takeaways: 🔹 Early, individualized tMCS initiation 🔹 Weigh ischemic vs bleeding risks 🔹 Multidisciplinary care is key! UChicago Medicine TecSalud - Sistema de Salud del Tec de Monterrey Vicente Jimenez-Franco MD 🇲🇽🫀

Kicking off Day 2 at #CShockLATAM2025 with impactful clinical cases! 🚨

Key takeaways:
🔹 Early, individualized tMCS initiation
🔹 Weigh ischemic vs bleeding risks
🔹 Multidisciplinary care is key!

<a href="/UChicagoMed/">UChicago Medicine</a> <a href="/TecSaludMX/">TecSalud - Sistema de Salud del Tec de Monterrey</a> <a href="/vicentejmzmd/">Vicente Jimenez-Franco MD 🇲🇽🫀</a>
Renata Quevedo (@rennquevedo) 's Twitter Profile Photo

✨Today’s #CSLATAM2025 session on MCS highlights: 🔹 Smaller, stronger devices under FDA review 🔹 ECMO: no proven survival benefit, but role in select cases 🔹 LV unloading & VADs driving HF care 🔹 The era of MCS innovation is here 🚀 Vicente Jimenez-Franco MD 🇲🇽🫀 Babar Basir Jaime Hernandez-Montfort

✨Today’s #CSLATAM2025 session on MCS highlights:

🔹 Smaller, stronger devices under FDA review
🔹 ECMO: no proven survival benefit, but role in select cases
🔹 LV unloading &amp; VADs driving HF care
🔹 The era of MCS innovation is here 🚀

<a href="/vicentejmzmd/">Vicente Jimenez-Franco MD 🇲🇽🫀</a> <a href="/Babar_Basir/">Babar Basir</a> <a href="/JHMontfort10/">Jaime Hernandez-Montfort</a>
Sandeep Nathan, MD, MSc (@sandeepnathanmd) 's Twitter Profile Photo

Thank you Vicente Jimenez-Franco MD 🇲🇽🫀, Dr. Guillermo Torre & #CShockLATAM25 team for the opportunity to present & moderate. High level content in an intimate, interactive setting - congrats on a great #CardiogenicShock meeting!

Thank you <a href="/vicentejmzmd/">Vicente Jimenez-Franco MD 🇲🇽🫀</a>, Dr. Guillermo Torre &amp; #CShockLATAM25 team for the opportunity to present &amp; moderate.  High level content in an intimate, interactive setting - congrats on a great #CardiogenicShock meeting!
Vicente Jimenez-Franco MD 🇲🇽🫀 (@vicentejmzmd) 's Twitter Profile Photo

Wrapping up two inspiring days in Cancun at the 3rd Cardiogenic Shock LATAM Symposium! An incredible gathering dedicated to one of cardiovascular care’s greatest challenges. Grateful to our speakers & participants for driving collaboration, innovation, and progress in CS

Renata Quevedo (@rennquevedo) 's Twitter Profile Photo

Wrapping up an incredible #CSLATAM2025 💙 The energy, organization, and leadership made this symposium unforgettable. 👏🏼 Inspired by days full of learning, teamwork, and innovation. #CShockLATAM25 #TecSalud

Wrapping up an incredible #CSLATAM2025 💙
The energy, organization, and leadership made this symposium unforgettable. 👏🏼

Inspired by days full of learning, teamwork, and innovation.
#CShockLATAM25 #TecSalud